Page 4 of 16

PA34.1-3 | CNS Infections & Tumors — SDL Guide (Part 4)

CNS Tumors — Classification Principles

Primary CNS tumors arise from brain parenchyma, meninges, or cranial nerve sheaths. Secondary (metastatic) tumors arise elsewhere and spread to the CNS.

Critical fact: In adults, metastatic tumors are more common than primary tumors. The most common sources of brain metastases are:
1. Lung (most common overall — especially small cell carcinoma and adenocarcinoma)
2. Breast
3. Melanoma (highest propensity to metastasise per primary tumor)
4. Kidney (RCC)
5. Colon
Mnemonic: "Look, Beautiful, My Kidney Colon" — Lung, Breast, Melanoma, Kidney, Colon.

Classification of primary CNS tumors:

I. Glial tumors (Gliomas) — most common primary CNS tumors; arise from glial cells:
Astrocytomas (from astrocytes) — includes glioblastoma (Grade 4)
Oligodendroglioma (from oligodendrocytes)
Ependymoma (from ependymal cells lining ventricles)

II. Non-glial tumors:
Meningioma — from arachnoid cap cells
Medulloblastoma — from cerebellar primitive cells (embryonal tumor)
Schwannoma — from Schwann cells of cranial nerves
Primary CNS lymphoma — usually B-cell; associated with HIV
Craniopharyngioma — from Rathke's pouch remnants; suprasellar

WHO grading (Grade 1–4): Based on mitosis, necrosis, vascular proliferation, and molecular markers. Grade 4 = highest malignancy, shortest survival.

Two-panel diagram: left panel shows a hierarchical branching classification tree of primary CNS tumors divided into glial (astrocytoma grades 1–4, oligodendroglioma, ependymoma) and non-glial (meningioma, medulloblastoma, schwannoma) categories; right panel shows a sagittal brain silhouette with numbered location pins indicating the typical anatomical site for each tumor type.

Classification of Primary CNS Tumors and Their Anatomical Locations

Panel A: Root node: Primary CNS Tumors; Left branch (blue): Glial Tumors — Astrocytoma Grade 1 (Pilocytic), Grade 2 (Diffuse), Grade 3 (Anaplastic), Grade 4 (GBM, deep red), Oligodendroglioma, Ependymoma; Right branch (orange): Non-Glial Tumors — Meningioma, Medulloblastoma (pediatric star icon), Schwannoma; Grade color gradient: light blue → yellow → orange → deep red. Panel B: Sagittal brain silhouette with 6 location pins: Pin 1 GBM/Astrocytoma at cerebral white matter (frontal-temporal); Pin 2 Oligodendroglioma at frontal cortex; Pin 3 Ependymoma at 4th ventricle / spinal central canal; Pin 4 Meningioma at falx cerebri / convexity; Pin 5 Medulloblastoma at cerebellar vermis (posterior fossa midline); Pin 6 Schwannoma at cerebellopontine angle (CN VIII).

Glioblastoma (Astrocytoma Grade 4) — Pathology and Molecular Markers

Glioblastoma (GBM) is the most common and most malignant primary brain tumor in adults. Mean age of onset: 55–65 years. Median survival: 12–15 months despite surgery + radiotherapy + temozolomide.

Molecular markers — essential for exam and clinical management:

  • IDH1/IDH2 mutation: Isocitrate dehydrogenase mutation is the most important prognostic marker. IDH-wild type GBM = primary GBM (de novo, worse prognosis, majority of adult GBMs). IDH-mutant GBM = secondary GBM (arises from lower-grade astrocytoma, slightly better prognosis). IDH mutation → 2-hydroxyglutarate accumulation → epigenetic reprogramming → tumorigenesis.
  • MGMT promoter methylation: O-6-methylguanine-DNA methyltransferase is a DNA repair enzyme. Methylation of MGMT promoter silences it → tumor cannot repair alkylating-agent damage → better response to temozolomide chemotherapy. ~40% of GBMs are MGMT-methylated — these patients do significantly better.
  • EGFR amplification: Common in primary GBM. Epidermal growth factor receptor overexpression drives cell proliferation.

Gross pathology:
• Large irregular mass with central necrosis and haemorrhage (variegated cut surface — grey-white necrotic areas, yellow necrotic core, red haemorrhagic areas — resembling a butterfly across the corpus callosum in butterfly glioma).
• Poorly defined margins — infiltrates surrounding brain widely.
Satellite lesions may be present.

Microscopy — two pathognomonic features:
1. Pseudopalisading necrosis (serpentine/geographic necrosis) — areas of necrosis rimmed by densely packed tumour cells arranged in a palisade (picket-fence pattern) as cells migrate away from the hypoxic centre.
2. Microvascular proliferation (glomeruloid bodies) — tufted, multilayered, thickened vessel walls resembling renal glomeruli — driven by VEGF released by hypoxic tumor cells.

Additionally: high mitotic rate, nuclear pleomorphism, hypercellularity.

Two-panel illustration: Panel A shows medium-power H&E histology of glioblastoma with pseudopalisading necrosis, geographic necrotic zones, and glomeruloid microvascular proliferation labeled; Panel B shows a gross coronal brain section with variegated cut surface, central necrosis, and haemorrhage labeled.

Glioblastoma: Histology and Gross Pathology

Panel A: Pseudopalisading necrosis (collar of palisading tumor nuclei around necrotic edge), Geographic/serpentine necrosis (central pale acellular zone), Glomeruloid microvascular proliferation (tufted multilayered endothelial capillary balls), Hypercellular astrocytic tumor (pleomorphic background tumor cells). Panel B: Central necrosis (chalky yellow-white necrotic core), Haemorrhage (dark red hemorrhagic zones), Variegated cut surface (mixed necrosis + hemorrhage + viable tumor rim).

Oligodendroglioma and Ependymoma

Oligodendroglioma:

  • Arises from oligodendrocytes. Grade 2 (low grade) or Grade 3 (anaplastic). Typically in the frontal lobe in adults (30–40s).
  • 1p/19q codeletion — the defining molecular alteration; seen in virtually 100% of true oligodendrogliomas. This codeletion confers better prognosis and sensitivity to procarbazine–CCNU–vincristine (PCV) chemotherapy.
  • IDH mutation is also present (IDH-mutant + 1p/19q codeleted = WHO oligodendroglioma).
  • Gross: Soft, gelatinous tumour, often with calcification (seen on CT as stippled calcification).
  • Microscopy"fried egg appearance": round uniform nuclei surrounded by abundant clear cytoplasm (due to formalin fixation artefact causing perinuclear halo). No fibrillary processes. Chicken-wire vascular pattern (delicate branching capillaries).
Three-panel H&E histology diagram of oligodendroglioma showing medium-power fried-egg cell appearance with perinuclear halos, chicken-wire capillary pattern, and dystrophic calcification, with high-power detail insets of the fried-egg cells and vascular mesh.

Oligodendroglioma Histology — Fried-Egg Cells, Chicken-Wire Vasculature, and Calcification

Panel A: Fried-egg cells (uniform round nuclei with clear perinuclear halos), chicken-wire vasculature (delicate capillary network), calcification (purple-blue dystrophic deposits) — medium-power overview. Panel B: Round uniform nucleus, clear perinuclear halo, cell membrane — high-power fried-egg cell morphology. Panel C: Chicken-wire capillary (thin-walled vessels forming geometric mesh), tumor cells in interstices, calcification nodule — vascular pattern detail.

Ependymoma:

• Arises from ependymal cells lining ventricles and spinal canal. Peak: children and young adults.
• Location: Intracranial ependymomas — 4th ventricle (children); Spinal ependymomas — filum terminale/conus medullaris (adults, most common spinal cord tumor).
Microscopy — two characteristic structures:
1. Perivascular pseudorosettes — tumor cells arranged radially around blood vessels with a fibrillary anucleate zone (most common).
2. True ependymal rosettes — columnar cells arranged around a central lumen (less common but pathognomonic).
RELA fusion — important in Grade 3 supratentorial ependymoma (poor prognosis).

Three-panel histology diagram of ependymoma: Panel A shows a medium-power H&E overview with both pseudorosettes and a true rosette labeled; Panel B is a high-power detail of a perivascular pseudorosette showing the central vessel, anucleate fibrillary zone, and surrounding tumor nuclei; Panel C is a high-power detail of a true ependymal rosette showing columnar cells around a central lumen.

Ependymoma — Perivascular Pseudorosettes and True Ependymal Rosettes (H&E, Medium & High Power)

Panel A: Medium-power H&E field; perivascular pseudorosettes (multiple, labeled with arrow); true ependymal rosette (one, labeled with arrow); ependymal tumor cells; background fibrillary matrix. Panel B: Central blood vessel wall; anucleate fibrillary zone (GFAP+ processes); outer ring of tumor cell nuclei; pseudorosette boundary. Panel C: Central lumen (empty); columnar ependymal cells; basally placed oval nuclei; apical surface with cilia suggestion.

CLINICAL PEARL

Molecular markers in glioma — 3 you MUST know for exams:

  1. IDH mutation → present in low-grade gliomas (Grade 2–3) and secondary GBM → BETTER prognosis vs IDH-wild type (which is primary GBM, worse prognosis). Think: IDH-mutant = Improving/better prognosis.
  2. 1p/19q codeletion → defines oligodendroglioma; associated with better chemosensitivity. Codeletion + IDH mutation = textbook oligodendroglioma.
  3. MGMT methylation → predicts response to temozolomide in GBM. Ask: is the tumor's DNA-repair enzyme silenced? If yes, chemotherapy works better.

Exam trap: WHO 2021 now requires molecular markers (IDH, 1p/19q) to diagnose glioma types — histology alone is insufficient for classification. A tumor with 'fried-egg' histology but no 1p/19q codeletion is NOT an oligodendroglioma by current WHO criteria.